Caisse de Depot et Placement du Quebec (CDPQ)’s Myriad Genetics MYGN Stock Holding History

Caisse de Depot et Placement du Quebec (CDPQ)’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-265,819	Closed	-$12.2M	–	757
2018 Q3	$12.2M	Hold	265,819	–	–	0.03%	228
2018 Q2	$9.93M	Sell	265,819 -34,181	-11%	-$1.15M	0.02%	261
2018 Q1	$8.87M	Sell	300,000 -150,000	-33%	-$5.08M	0.02%	259
2017 Q4	$15.5M	Buy	450,000 +200,000	+80%	+$6.75M	0.04%	204
2017 Q3	$9.08M	Buy	+250,000	New	+$7.13M	0.02%	257

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ)'s MYGN Position: Q4 2018 in Review

Caisse de Depot et Placement du Quebec (CDPQ) sold out of Myriad Genetics (MYGN) in Q4 2018, closing a stake of 265,819 shares — an estimated $12.2M sold.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in MYGN in Q3 2017 and held it in 5 quarters. The position peaked at $15.5M in Q4 2017. 264 funds tracked by Wall St. Rank hold MYGN as of Q4 2018.

Caisse de Depot et Placement du Quebec (CDPQ) reported no remaining Myriad Genetics position as of Q4 2018 after selling out during the quarter.
Caisse de Depot et Placement du Quebec (CDPQ) sold 265,819 Myriad Genetics shares in Q4 2018, an estimated $12.2M.
Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in Myriad Genetics in Q3 2017 and held it in 5 quarters.
Caisse de Depot et Placement du Quebec (CDPQ)'s Myriad Genetics position peaked at $15.5M in Q4 2017.
264 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2018.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q4 2018, filed 14 Feb 2019.